Internationally, 20 million women are living with HIV and in South Africa, an estimated 3 million people are living with HIV (WHO, 2002). Currently, prevention of maternal to child transmission (PMTCT) programs are being mounted internationally to stop transmission of HIV during childbirth. However, the needs of Mothers Living with HIV (MLH) do not stop with childbirth as they face the challenges of caring for their own health, stopping transmission acts, parenting while ill, and coping with significant stress on an ongoing basis. The goal of this proposed studies is to adapt an intervention demonstrated as efficacious in the United States with parents living with HIV (Rotheram-Borus et al., 2001a, 2001b, 2003, & in submission) and young people living with HIV (Rotheram-Borus et al., 2001a, b, in submission). Building on a relationship and preliminary work of Dr. Futterman in South Africa with the Provincial Health Ministry during the scaling up of the PMTCT program and her work with Dr. Mitchell Besser, the director of a South African NGO- Mothers to Mothers, the ongoing collaborations of Albert Einstein & UCLA, and recent collaborative field work by Drs. Futterman & Rotheram-Borus in South Africa, the potential adaptability of the U.S. programs to South Africa appear promising. We propose a two-phase project over two years. Following one year of cultural adaptation, a pilot evaluation of the outcomes of the adapted intervention will be conducted with 100 MLH in Khayelitsha Township in Cape Town, South Africa to prepare for a large randomized controlled trial with MLH. Qualitative information to guide the adaptation will be gathered via key informant interviews and focus groups with: care providers (nurses, physicians, home health care workers), administrators in government and non governmental organizations and MLH in order to ensure feasibility and replication of the intervention and assessment measures. In year 2, a pilot evaluation of the program will be conducted with 100 MLH at two different clinic settings who will be randomly assigned by clinic setting to either: 1) standard care which includes social support groups (Mothers to Mothers program); or 2) an enhanced care condition (Healthy Families) which includes four modules of four sessions each focused on skill-building, affective self-regulation, and enhancing coping. The four domains of caring for one's own health, reducing transmission, parenting, and maintaining mental health will be the focus of the intervention and assessment. Potential secondary outcomes are disclosure of serostatus, extended family relationships and perceived social support, health care utilization and assertiveness with health care provider, In addition, the health status of children will be assessed including measures such as weight, developmental milestones and HIV status at one year if funding permits this follow up. If successful, this adaptation can serve as an important adjunct to PMTCT programs that are scaling up throughout the world. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI051519-02S1
Application #
6773035
Study Section
Special Emphasis Panel (ZAI1-GB-A (J2))
Program Officer
Young, Janet M
Project Start
2003-05-15
Project End
2008-04-30
Budget Start
2004-09-30
Budget End
2008-04-30
Support Year
2
Fiscal Year
2004
Total Cost
$270,203
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Lankowski, Alexander J; Bien-Gund, Cedric H; Patel, Viraj V et al. (2018) PrEP in the Real World: Predictors of 6-Month Retention in a Diverse Urban Cohort. AIDS Behav :
Kirichenko, Tatiana V; Myasoedova, Veronika A; Shimonova, Tatiana E et al. (2018) Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection. Biosci Rep 38:
Auld, Sara C; Shah, N Sarita; Mathema, Barun et al. (2018) Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities. Eur Respir J 52:
Harbut, Michael B; Yang, Baiyuan; Liu, Renhe et al. (2018) Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angew Chem Int Ed Engl 57:3478-3482
Patel, Viraj V; Dange, Alpana; Rawat, Shruta et al. (2018) Barriers to HIV Testing Among Men Who Have Sex With Men in India Reached Online: Implications for Interventions. J Acquir Immune Defic Syndr 78:e30-e34
Vilchèze, Catherine; Kim, John; Jacobs Jr, William R (2018) Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice. Antimicrob Agents Chemother 62:
Patel, Viraj V; Ginsburg, Zoë; Golub, Sarit A et al. (2018) Empowering With PrEP (E-PrEP), a Peer-Led Social Media-Based Intervention to Facilitate HIV Preexposure Prophylaxis Adoption Among Young Black and Latinx Gay and Bisexual Men: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc 7:e11375
Snapp, Erik Lee; McCaul, Nicholas; Quandte, Matthias et al. (2017) Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide. Elife 6:
Kelso-Chichetto, N E; Plankey, M; Sheps, D S et al. (2017) The impact of long-term moderate and heavy alcohol consumption on incident atherosclerosis among persons living with HIV. Drug Alcohol Depend 181:235-241
Megra, Bezawit W; Eugenin, Eliseo A; Berman, Joan W (2017) The Role of Shed PrPc in the Neuropathogenesis of HIV Infection. J Immunol 199:224-232

Showing the most recent 10 out of 531 publications